Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

Cited In for PubMed (Select 9619196)

1.

The ecology of human fear: survival optimization and the nervous system.

Mobbs D, Hagan CC, Dalgleish T, Silston B, Prévost C.

Front Neurosci. 2015 Mar 18;9:55. doi: 10.3389/fnins.2015.00055. eCollection 2015.

2.

Proof of principle: Transformation approach alters caudate nucleus volume and structure-function associations.

Schwab NA, Tanner JJ, Nguyen PT, Schmalfuss IM, Bowers D, Okun M, Price CC.

Brain Imaging Behav. 2014 Nov 21. [Epub ahead of print]

PMID:
25413122
3.

Subclinical visuospatial impairment in Parkinson's disease: the role of Basal Ganglia and limbic system.

Caproni S, Muti M, Di Renzo A, Principi M, Caputo N, Calabresi P, Tambasco N.

Front Neurol. 2014 Aug 11;5:152. doi: 10.3389/fneur.2014.00152. eCollection 2014.

4.

Functional connectivity in the basal ganglia network differentiates PD patients from controls.

Szewczyk-Krolikowski K, Menke RA, Rolinski M, Duff E, Salimi-Khorshidi G, Filippini N, Zamboni G, Hu MT, Mackay CE.

Neurology. 2014 Jul 15;83(3):208-14. doi: 10.1212/WNL.0000000000000592. Epub 2014 Jun 11.

5.

Entacapone reduces cortical activation in Parkinson's disease with wearing-off: a f-MRI study.

Tambasco N, Muti M, Chiarini P, Tarducci R, Caproni S, Castrioto A, Nigro P, Parnetti L, Floridi P, Rossi A, Calabresi P.

PLoS One. 2014 May 15;9(5):e96806. doi: 10.1371/journal.pone.0096806. eCollection 2014.

6.

Large-scale resting state network correlates of cognitive impairment in Parkinson's disease and related dopaminergic deficits.

Lebedev AV, Westman E, Simmons A, Lebedeva A, Siepel FJ, Pereira JB, Aarsland D.

Front Syst Neurosci. 2014 Apr 3;8:45. doi: 10.3389/fnsys.2014.00045. eCollection 2014.

7.

Complexity of motor sequences and cortical reorganization in Parkinson's disease: a functional MRI study.

Caproni S, Muti M, Principi M, Ottaviano P, Frondizi D, Capocchi G, Floridi P, Rossi A, Calabresi P, Tambasco N.

PLoS One. 2013 Jun 25;8(6):e66834. doi: 10.1371/journal.pone.0066834. Print 2013.

8.

Diminished activation of motor working-memory networks in Parkinson's disease.

Rottschy C, Kleiman A, Dogan I, Langner R, Mirzazade S, Kronenbuerger M, Werner C, Shah NJ, Schulz JB, Eickhoff SB, Reetz K.

PLoS One. 2013 Apr 19;8(4):e61786. doi: 10.1371/journal.pone.0061786. Print 2013.

9.

Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease.

Christopher L, Strafella AP.

J Neuropsychol. 2013 Sep;7(2):225-40. doi: 10.1111/jnp.12015. Epub 2013 Apr 1. Review.

10.

Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsylvania and the University of Washington.

Watson GS, Cholerton BA, Gross RG, Weintraub D, Zabetian CP, Trojanowski JQ, Montine TJ, Siderowf A, Leverenz JB.

Alzheimers Dement. 2013 Sep;9(5):609-14. doi: 10.1016/j.jalz.2012.07.006. Epub 2012 Nov 16.

11.

Cannabinoids and value-based decision making: implications for neurodegenerative disorders.

Lee AM, Oleson EB, Diergaarde L, Cheer JF, Pattij T.

Basal Ganglia. 2012 Sep 1;2(3):131-138. Epub 2012 Jul 28.

12.

The epidemiology and clinical manifestations of dysexecutive syndrome in Parkinson's disease.

Ceravolo R, Pagni C, Tognoni G, Bonuccelli U.

Front Neurol. 2012 Nov 8;3:159. doi: 10.3389/fneur.2012.00159. eCollection 2012.

13.

Thalamic projection fiber integrity in de novo Parkinson disease.

Planetta PJ, Schulze ET, Geary EK, Corcos DM, Goldman JG, Little DM, Vaillancourt DE.

AJNR Am J Neuroradiol. 2013 Jan;34(1):74-9. doi: 10.3174/ajnr.A3178. Epub 2012 Jul 5.

14.

Role of basal ganglia circuits in resisting interference by distracters: a swLORETA study.

Bocquillon P, Bourriez JL, Palmero-Soler E, Destée A, Defebvre L, Derambure P, Dujardin K.

PLoS One. 2012;7(3):e34239. doi: 10.1371/journal.pone.0034239. Epub 2012 Mar 28.

15.

Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits?

Helmich RC, Hallett M, Deuschl G, Toni I, Bloem BR.

Brain. 2012 Nov;135(Pt 11):3206-26. doi: 10.1093/brain/aws023. Epub 2012 Mar 1. Review.

16.

Prefrontal dopaminergic receptor abnormalities and executive functions in Parkinson's disease.

Ko JH, Antonelli F, Monchi O, Ray N, Rusjan P, Houle S, Lang AE, Christopher L, Strafella AP.

Hum Brain Mapp. 2013 Jul;34(7):1591-604. doi: 10.1002/hbm.22006. Epub 2012 Feb 14.

17.

Cognitive rehabilitation in Parkinson's disease: evidence from neuroimaging.

Nombela C, Bustillo PJ, Castell PF, Sanchez L, Medina V, Herrero MT.

Front Neurol. 2011 Dec 22;2:82. doi: 10.3389/fneur.2011.00082. eCollection 2011.

18.

Frontostriatal cognitive staging in Parkinson's disease.

de la Fuente-Fernández R.

Parkinsons Dis. 2012;2012:561046. doi: 10.1155/2012/561046. Epub 2011 Dec 6.

19.

Emotional dysfunction in Parkinson's disease.

Blonder LX, Slevin JT.

Behav Neurol. 2011;24(3):201-17. doi: 10.3233/BEN-2011-0329. Review.

20.

Upregulation of cathepsin D in the caudate nucleus of primates with experimental parkinsonism.

Yelamanchili SV, Chaudhuri AD, Flynn CT, Fox HS.

Mol Neurodegener. 2011 Jul 21;6:52. doi: 10.1186/1750-1326-6-52.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk